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Can blood serum amyloid A 
concentrations in horses differentiate 
synovial sepsis from extrasynovial 
inflammation and determine response 
to treatment?
Matthew Sinovich   ,1 Nicolas F Villarino,2 Ellen Singer,3 Claire S Robinson,4 Luis M Rubio- Martínez1,5
Abstract
Background Serum amyloid A (SAA) concentrations in blood and synovial fluid of horses with synovial sepsis 
have diagnostic value. Studies suggest serial blood SAA measurements could act as a prognostic indicator. This 
study evaluated the use of serial blood SAA concentrations for monitoring of horses with synovial sepsis.
Methods A prospective clinical trial was performed of horses referred to a single hospital with synovial sepsis 
that survived (n=17), synovial sepsis that were euthanised (n=5), non- septic intrasynovial pathologies (n=14) or 
extensive extrasynovial lacerations (n=5). SAA concentrations were determined on admission and every 24 hours 
thereafter. The area under the concentration–time curve from 0 to 144 hours of each group was compared by 
Kruskal- Wallis and post hoc Dunn’s tests (P<0.05).
Results Significant difference in mean blood concentration of SAA was found between synovial sepsis that 
survived and non- septic pathologies in the first 48 hours, as well as between non- septic intrasynovial pathologies 
and non- responsive sepsis requiring euthanasia. No difference was found between extensive extrasynovial 
lacerations and any septic group.
Conclusions While serial blood SAA is useful for monitoring clinical response of intrasynovial septic 
pathologies, interpretation should consider other clinical findings since blood SAA is not a specific marker for 
synovial sepsis.
Introduction
Serum amyloid A (SAA), one of the main acute 
phase proteins in horses,1–3 has been shown to be 
a differentiating factor for septic and non- septic 
inflammatory conditions including synovitis.2 4–8 When 
a horse acquires an extensive laceration or synovial 
contamination, the introduction of foreign material 
and pathogens stimulates a marked inflammatory 
response2 9 with local swelling, pain and heat. In 
synovial structures, this response will eventually 
lead to the enzymatic breakdown of hyaluronic acid 
and cartilage.9 10 The local release of cytokines such 
as interleukin- 1 (IL-1), tumour necrosis factor- alpha 
(TNF-α) and interleukin-6 (IL-6) from monocytes and 
macrophages at the site of injury drives the inflammatory 
response. Once released into the bloodstream, these 
pro- inflammatory cytokines stimulate synthesis of 
acute- phase proteins such as SAA by the liver.2 3
Monitoring response to treatment in horses with 
synovial sepsis has traditionally relied on white 
blood cell count and total protein determination in 
synovial fluid (SF) after repeated synoviocentesis.11 
However, those SF parameters are affected by routine 
synoviocentesis, administration of intrasynovial 
medication and surgical synovial treatments, which 
makes their clinical interpretation difficult in some 
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cases.2 7 12–16 The intrasynovial procedures listed seem 
to have a limited effect on blood SAA, which has been 
proposed as a potential parameter to monitor therapy 
and resolution of synovial sepsis.
Serum concentrations of SAA have been shown to 
peak 48 hours after the onset of inflammation.2 8 SAA 
can undergo a several thousand- fold increase from 
baseline values, followed by a rapid decrease in 
concentration once the infectious or inflammatory 
stimulus has been removed.2 3 8 A recent study compared 
SAA concentrations in blood and SF of horses with 
synovial sepsis to horses with non- septic synovial 
pathologies.12 Both blood and SF concentrations of SAA 
had diagnostic value in horses suffering from synovial 
sepsis.12 Another study monitored blood SAA values 
every 48 hours in horses undergoing treatment for 
synovial sepsis2 and agreed with these findings. These 
studies have suggested that serial measurements of SAA 
in horses with synovial sepsis could guide treatment 
and act as a prognostic indicator for survival.2 12
Systemic inflammatory and infectious conditions 
can also increase blood SAA concentrations,1 which 
if concurrent with septic synovitis could confound 
interpretation of results and limit the diagnostic or 
monitoring potential of SAA concentrations. Many 
cases of synovial sepsis occur as sequelae to significant 
wounds or trauma causing contamination of synovial 
cavities. If synovial sepsis is present in conjunction 
with a significant wound, peri- articular inflammation 
and/or infection could lead to increased systemic SAA 
concentration which would confound the interpretation 
of SAA values in relation to synovial sepsis.
Horses with non- septic intrasynovial pathology 
have been reported to have low synovial and serum SAA 
concentrations.12 17 While SAA concentrations in blood 
and SF did not increase after repeated intra- articular 
injection of antimicrobials or after arthroscopic or needle 
articular lavage,13–15 certain intrasynovial surgical 
techniques may involve significant tissue trauma that 
might increase systemic SAA.1 The effect of extensive 
extrasynovial lacerations or intrasynovial surgery on 
SAA has not been investigated or compared with values 
of SAA of horses with septic synovial structures.
The aim of this study was to compare the serial 
SAA concentrations in the blood of horses suffering 
from synovial sepsis with horses with non- septic 
intrasynovial pathologies and horses with extensive 
extrasynovial lacerations. Serial blood concentrations 
of SAA were compared in horses undergoing surgical 
treatment for synovial sepsis that survived, synovial 
sepsis that were euthanised, non- septic intrasynovial 
pathologies or extensive extrasynovial lacerations that 
underwent surgical debridement and repair under 
general anaesthesia. The authors hypothesised that 
serial blood SAA concentrations in horses with septic 
synovitis subjected to endoscopic treatment under 
general anaesthesia would be higher than in horses 
with non- septic intrasynovial pathology or extensive 
extrasynovial lacerations that underwent surgical 
treatment. The second hypothesis was that serial blood 
SAA concentrations in horses with septic synovitis 
which responded favourably to surgical therapy would 
be lower and decline faster than in those with synovial 
sepsis, which did not respond to treatment.
Materials and methods
Inclusion criteria
For this clinical longitudinal observational study, 
performed between May 2015 and August 2016, 
inclusion criteria were horses presented to a single 
equine referral hospital for surgical treatment of 
synovial sepsis, non- septic intrasynovial pathology 
or a significant laceration without the involvement of 
synovial structures which required wound debridement 
and reconstruction under general anaesthesia.
Study groups
Horses were included in one of four groups: group 
1—horses with confirmed synovial contamination or 
sepsis (S- SS), which were responsive to intrasynovial 
endoscopic treatment; group 2—horses with non- 
septic intrasynovial pathology (S- NS) which underwent 
intrasynovial endoscopic surgery; group 3—horses with 
confirmed synovial sepsis (S- SE), which failed to respond 
to surgical endoscopic treatment and were euthanised; 
group 4—horses with extensive lacerations, which did 
not involve synovial structures and underwent surgical 
wound debridement and reconstruction (ES- L). All 
horses underwent general anaesthesia for the required 
procedures.
Horses were included in the S- SS group if they 
met one or more of the following criteria12: synovial 
fluid parameters consistent with synovial sepsis (total 
nucleated cell count >20×109 cells/L, total neutrophil 
percentage over 80 per cent and a total protein over 
30 g/L); direct communication of a wound with a 
synovial cavity established visually, endoscopically or 
visualisation of fluid from joint pressure test; positive 
bacterial culture from synovial fluid or membrane 
sample; presence of intracellular bacteria on a synovial 
fluid smear. Horses were included in the S- NS group if 
they underwent endoscopy for intrasynovial conditions 
including osteoarthritis, osteochondrosis, intra- 
articular fracture and non- septic tenosynovitis. Horses 
were included in the S- SE group if they met the criteria 
for synovial sepsis as for the SS- S group, showed 
no clinical response to endoscopic lavage and were 
euthanised.
Horses were included in the ES- L group if they had 
a laceration, which did not involve a synovial structure 
but required surgical debridement and repair under 
general anaesthesia. Horses with other concurrent 
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Table 1 Synovial structures affected in the horses included in the study
Structure affected Horses (n)





Distal interphalangeal joint 6
Calcanean bursa 2
Scapulohumeral joint 1
Median serum concentration of SAA
































Figure 1 Median concentration versus time of blood serum amyloid A (SAA) in 
horses included in the study. ES- L (n=5), extrasynovial lacerations; S- NS (n=14), 
non- septic intrasynovial; S- SE (n=5), synovial sepsis—euthanised; S- SS (n=17), 
synovial sepsis—survived. Time zero indicates the day of admission.
Sample collection and processing
Jugular blood samples were collected in plain tubes 
with clot activator (BD Vacutainer, Belliver Industrial 
Estate, Plymouth, UK) from the horses on the day of 
admission prior to anaesthesia and then every 24 hours 
until discharge or euthanasia. Samples were centrifuged 
within 10 min of collection at 4000 g for 15 min at 4°C. 
Serum was removed and stored at –80°C until analysis 
was performed as previously described.12
SAA quantification
All sample analysis was performed by a single operator 
to limit variability.12 The samples were removed from the 
freezer, thawed at room temperature and then processed 
immediately. The SAA concentration was determined 
with an automated chemistry analyser (IDEXX 
Catalyst One; IDEXX Laboratories Limited, St. Helens, 
Merseyside, UK) with a human SAA turbidometric 
immunoassay (Eiken LZ SAA test; Eiken Chemical Mast 
group, Bootle, Merseyside, UK) previously validated for 
use on equine samples.7 12 15 18 A zero value was assigned 
to any concentrations which were below the limit of 
detection which was 0.5 µg/ml.12
Statistical analysis
Descriptive statistics were performed and where 
appropriate data are presented as median (range). 
Blood SAA concentrations were plotted versus the 
time points and the area under concentration versus 
time curve from 0 to 144 hours was calculated by the 
trapezoid rule.19 The AUC was not normally distributed 
(Shapiro- Wilk test P>0.05). The median AUC for each 
group was compared using Kruskal- Wallis test and post 
hoc Dunn’s test was then performed. Statistical analysis 
was performed using R studio V.3.1. The significance 
level was set at P value <0.05.
Results
Forty- one horses were included in the study: S- SS 
(n=17), S- NS (n=14), S- SE (n=5) and NS- L (n=5). The 
study groups included 21 geldings and 14 mares. 
Horses included one Appaloosa, three Arabians, three 
Irish Cobs, one Connemara, four Irish Draft crosses, 
six Irish Sport horses, one pony, one Shire cross, six 
Thoroughbreds, four Thoroughbred crosses, four 
Warmbloods and five Welsh horses. The median age of 
horses was 12 years (range, 2–19 years). Distributions 
of structures affected are listed in table  1. The 
aetiology of sepsis included sepsis post intrasynovial 
medication,1 puncture wounds10 and traumatic wounds 
and lacerations.11
The temporal kinetics of SAA blood concentrations 
in horses included in the study are shown in figure 1. 
A scatterplot of the blood SAA values for the first three 
time points has been included as figure 2 to show the 
distribution of values among groups. The S- SS group 
had a median blood concentration of SAA of 296.2 µg/
ml on admission that peaked at 796 µg/ml after day 
2 and then tapered off over the following time points 
(table  2). Concentrations of blood SAA in S- SS group 
were significantly higher than the S- NS group at 
admission, day 1 and day 2.
The S- NS group had significantly lower median 
blood concentrations of SAA than all other groups for 
the first 4 days. Blood concentration of SAA in the S- NS 
group was significantly lower than all other groups at 
admission. Blood SAA was also significantly lower than 
both the S- SS and S- SE group at days 1 and 2. At day 
3, SAA in S- NS group was still significantly lower than 
the S- SE group. Significant P values are summarised in 
table 3.
Some of the highest median blood SAA concentrations 
on admission were obtained in the S- SE group (1049 µg/
ml; range, 8.7–2139.1 µg/ml). The median increased 
at day 1 and then decreased gradually. Blood SSA in 
S- SE was significantly different to the S- NS group at 
admission as well as at days 1, 2 and 3.
The ES- L group had a median SAA value on 
admission of 275 µg/ml which was similar to the SS- S 
group but significantly elevated relative to the S- NS 
group, with no difference compared with the S- SE 
group. The blood SAA level of the ES- L group increased 
to a peak at day 3 and then decreased. There were no 
significant differences between the ES- L group and any 
other group at any other time point.
The AUC of blood SAA in S- NS was significantly 
lower than both the S- SS and S- SE (P=0.0001) groups. 
The AUC of the S- SE groups was significantly higher 
than the S- NS group (P<0.0001) but not significantly 
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Figure 2 Scatter plot of blood serum amyloid A (SAA) values for all horses. 
The X- axis shows the first three time points (days) and the Y- axis shows the 
distribution of values (µg/ml). ES- L, extrasynovial lacerations; S- NS, non- septic 
intrasynovial; S- SE, synovial sepsis—euthanised; S- SS, synovial sepsis—survived.
Table 2 Median concentrations of SAA per group at admission and over the first 4 days
Groups
Blood SAA (µg/ml) concentration for time points (days) Median AUC (µg*h/ml)
Days 1 2 3 4
S- SS Median 296 780 796 687 59 933
Range 9–1939 55–1359 220–1510 145–1103
S- NS Median 4 300 192 159 9082
Range 0–245 9–368 6–380 12–862
S- SE Median 1049 1942 1419 1110 152 942
Range 8–2139 363–3130 607–1791 611–1110
ES- L Median 275 492 749 606 63 701
Range 24–642 350–817 433–894 464–692
Median AUC is shown for group in the final column.
ES- L, extrasynovial laceration; SAA, serum amyloid A; S- NS, synovial non- septic; S- SE, synovial septic euthanased; S- SS, synovial septic survived.
different compared with the other groups. The AUC of 
the ES- L group was also not significantly different to 
any group.
Discussion
In this study, blood concentrations of SAA were 
monitored daily in horses undergoing surgical 
treatment for synovial sepsis, synovial conditions 
other than sepsis and extrasynovial lacerations. This 
study has shown that serial blood concentrations of 
SAA are useful as indicators of response to treatment in 
horses with synovial sepsis or contamination following 
treatment; however, concurrent conditions other than 
synovial sepsis can produce a significant inflammatory 
stimulus leading to increased blood SAA values which 
can be confounding.
Previous studies have shown that blood SAA levels 
in horses with septic synovial structures should 
decrease with a positive response to treatment.1 2 These 
findings were supported by the current study with 
blood SAA concentrations in the S- SS similar to those 
in the S- NS group by day 3 post- surgery. Horses with 
synovial sepsis that did not respond to treatment had 
higher blood SAA values initially with a decrease after 
surgical treatment; however, at 4 days, values remained 
above 600 µg/ml. Unfortunately, the variability of SAA 
values and the limited number of cases included in 
this study did not allow the authors to define cut- off 
values between responding and non- responding cases. 
Similar variability in SAA values has been reported in 
other studies2 12 20 and may reflect different severity 
of inflammatory stimulus, bacterial load and/or 
virulence.1 9 Despite the lack of a clear cut- off value, 
serial SAA measurements can assist with clinical 
decision- making and the trend in values may be used in 
conjunction with other clinical parameters to determine 
response to treatment.
Blood concentrations of SAA have been shown 
to take 4–8 hours to elevate in a lipopolysaccharide- 
induced arthritis model in equines18 and have been 
reported to peak at 36 and 48 hours after experimental 
synovial inflammation and sepsis20 and synovial 
penetration injury,2 respectively. The chronicity of the 
insult was not recorded in the current study; however, 
in the reported population, the majority of cases of 
synovial sepsis and contamination are secondary to 
wounds and typically present to the hospital more than 
6–8 hours after the injury occurred. Similar to previous 
studies, horses responding to surgical intervention 
showed blood SAA falling to 200–300 µg/ml before 7–8 
days.2 20 Horses with synovial sepsis unresponsive to 
treatment showed the highest blood SAA concentrations 
throughout the study time, with values at the time 
of euthanasia within the range of 600–800 µg/ml, 
although these were not statistically different from 
the groups of sepsis that survived and significant 
lacerations. Production of SAA is related to the severity 
of the inflammatory stimulus,21 which is determined by 
the degree of contamination, tissue damage, bacterial 
load and bacterial virulence.1 9 Previous studies have 
reported high levels of SAA following complications 
after both elective and emergency surgeries in horses, 
which remained persistently high until resolution of 
the complications.2 17 22 Further studies are necessary 
to investigate potential association between SAA 
concentration and number of surgical procedures 
required and to further investigate the suggested 
association between SAA concentration and prognosis.
Synovial contamination and subsequent sepsis is 
a common sequela in horses following penetrating 
injury and remains a frequent occurrence in equine 
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Table 3 Summary of significant P values from Dunn’s comparisons of median SAA concentrations at the first four time points
Significant P values from Dunn’s comparisons of median blood SAA concentrations (µg/ml) at different time points (days) for different groups
Groups 0 1 2 3 4
S- SS vs S- NS 0.0002 0.0009 0.0007 X X
S- SS vs S- SE X X X X X
S- SS vs ES- L X X X X X
S- NS vs S- SE 0.0002 0.0009 0.0007 0.0082 X
S- NS vs ES- L 0.0002 X X X X
S- SE vs ES- L X X X X X
X indicates absence of statistical significance (P>0.05).
ES- L, extrasynovial lacerations; SAA, serum amyloid A; S- NS, synovial non- septic; S- SE, synovial septic euthanased; S- SS, synovial septic survived.
practice.2 10 23 24 This study shows that extensive 
extrasynovial pathology can represent a systemic 
inflammatory stimulus of similar magnitude to 
synovial sepsis and cause similar increased blood 
SAA concentrations. The reduction in blood SAA in 
the S- SS group should be interpreted as a resolution of 
infection and inflammation in both the intrasynovial 
and extrasynovial tissues. Elevation of blood SAA has 
also been recognised following castration in horses 
and median blood SAA in horses with castration site 
infection were 600–700 µg/ml for at least 8 days 
postoperatively, which are similar to horses with 
synovial sepsis that responded to treatment and horses 
with extrasynovial lacerations in this study.12 17 When 
interpreting blood SAA concentrations in horses treated 
for synovial infection, the contribution of extrasynovial 
inflammation should be carefully considered as blood 
SAA is not a specific marker for synovial sepsis.
Surgical trauma can cause increased blood SAA 
concentrations and the elevation is related to the 
degree of surgical trauma.1 In the S- NS group, horses 
that underwent arthroscopic surgical trauma had 
up to a hundredfold increase in median blood SAA 
concentration after surgery. Peak concentrations were 
recorded 48 hours (>300 µg/ml) after the surgical 
stimulus and then rapidly tapered off over the following 
48 hours. The curve of the peak concentration of 
blood SAA in the S- NS group remained lower than the 
ES- L group and the curve decreased more slowly, but 
there was no statistical difference after 24 hours. This 
suggests that although surgical trauma creates a marked 
stimulus for SAA production, it is below the intensity 
of a significant laceration with tissue inflammation 
and infection. The median blood SAA values after the 
peak seemed to decrease in a similar manner between 
the ES- L, S- NS and S- SS groups. The degree of elevation 
of blood SAA seen following endoscopic treatment 
was significantly higher (three times higher) than 
anticipated and is in contrast with previous literature.
Synovial fluid concentrations of SAA were not 
monitored since synoviocentesis on a routine basis 
cannot be justified in horses without synovial sepsis. 
Previous studies have shown moderate correlations 
between concentrations of SAA in blood and synovial 
fluid in horses, with higher blood SAA concentrations 
compared with synovial concentrations in cases of 
synovial sepsis.12 Although synoviocytes can produce 
SAA in the face of synovial inflammation or sepsis,18 
an extra- articular source of synovial SAA has been 
suggested in horses with synovial sepsis.12 In fact, 
systemically derived isoforms of SAA have been isolated 
in the synovial fluid of humans and horses7 25 and the 
liver is considered as the main source of SAA in the 
horse.18
Horses in this study with non- responsive synovial 
sepsis or contamination had the highest SAA values on 
admission and over the first 36 hours of hospitalisation. 
These high values could be related to a more serious 
infection, more virulent bacteria or longer time to 
referral, incomplete or insufficient lavage and/or 
debridement, foreign material, features which were not 
within the scope of this study. The lack of significant 
difference in the AUC in S- SE group compared with 
other groups with a favourable outcome may be due to 
the fact that 40% (2/5) of the horses in the S- SE group 
were euthanised earlier based on the lack of clinical 
improvement, with fewer serial blood samples obtained 
and therefore, limited AUC values. This may also be a 
lack of power due the number of horses included.
The majority of cases had received some NSAIDs 
prior to referral or during treatment. The role of NSAIDs 
on the response of acute phase proteins has yet to be 
evaluated in the horse. Studies in humans, dogs and 
ruminants provide conflicting evidence regarding the 
effect of NSAIDs on acute phase protein concentrations, 
with some studies showing that NSAIDs administration 
did not affect acute phase protein response in 
comparison with non- treated controls26 27 and other 
studies demonstrating the opposite.28 29
Limitations in the current study include the limited 
number of horses included and the fact that the 
number of blood samples differed among groups as 
was dependent on response to treatment, resolution 
of the disease or euthanasia. Due to the clinical nature 
of this study, factors such as synovial structures 
affected, synovial conditions, anatomical locations 
of lacerations, inciting causes of sepsis and time from 
injury to initial sample could not be controlled and are 
suspected to have contributed to variability in SAA data. 
Investigation of SAA response to synovial sepsis without 
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concurrent soft- tissue inflammation or infection may be 
warranted to help define cut- off values which would aid 
with clinical prognosis.
Conclusion
Blood SAA is not a specific marker for synovial sepsis in 
horses and interpretation of blood SAA concentrations 
should be performed in conjunction with other clinical 
findings. Serial monitoring of blood SAA in horses 
may be useful for monitoring clinical response of 
septic synovial pathologies; however, it is important to 
consider the effect on SAA concentrations of concurrent 
confounding pathologies such as significant lacerations.
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